Published in:
01-04-2010 | Case Report
Torsades de Pointes induced by a combination of garenoxacin and disopyramide and other cytochrome P450, family 3, subfamily A polypeptide-4-influencing drugs during hypokalemia due to licorice
Authors:
Kanyu Miyamoto, Hirohisa Kawai, Ryuhei Aoyama, Hitoshi Watanabe, Keisuke Suzuki, Norihiro Suga, Wataru Kitagawa, Naoto Miura, Kazuhiro Nishikawa, Hirokazu Imai
Published in:
Clinical and Experimental Nephrology
|
Issue 2/2010
Login to get access
Abstract
We report an 82-year-old man who developed ventricular tachycardia and Torsades de Pointes (TdP) after oral administration of garenoxacin, a novel quinolone antibiotic agent that differs from the third-generation quinolones, for pneumonia. He had hypokalemia (K 2.3 mmol/L) induced by licorice and also had received disopyramide for arrhythmia, bicalutamide for prostate cancer, and silodosin for prostate hypertrophy. After taking him off all drugs and administering spironolactone supplemented with potassium, his low serum potassium level was ameliorated. Therefore, although garenoxacin reportedly causes fewer adverse reactions for cardiac rhythms than third-generation quinolone antibiotics, one must be cautious of the interference of other drugs during hypokalemia in order to prevent TdP.